The California Stem Cell Report

Share this post

User's avatar
The California Stem Cell Report
California Stem Cell Merger: Capricor and Niles Therapeutics

California Stem Cell Merger: Capricor and Niles Therapeutics

David Jensen's avatar
David Jensen
Jul 10, 2013
∙ Paid

Share this post

User's avatar
The California Stem Cell Report
California Stem Cell Merger: Capricor and Niles Therapeutics
Share

Capricor, Inc., a Beverly Hills company benefiting from $27 million from the California stem cell agency, this week announced that it is merging with Niles Therapeutic, Inc., of San Mateo.

Linda Marban
Capricor photo

The Capricor story and its treatment for heart disease have been highlighted (see here and here) by the $3 billion state research agency, whi…

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 David Jensen
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share